Stock PTCT PTC THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News PTC Therapeutics, Inc.

Equities

PTCT

US69366J2006

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-15 pm EDT 		5-day change 1st Jan Change
25.68 USD -2.80% Intraday chart for PTC Therapeutics, Inc. -4.46% -6.82%
Mar. 28 PTC Therapeutics Seeks EMA Marketing Authorization for Sepiapterin for Phenylketonuria Treatment MT
Mar. 28 PTC Therapeutics, Inc. Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results
AQ
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results
PR
PTC Therapeutics Seeks EMA Marketing Authorization for Sepiapterin for Phenylketonuria Treatment
MT
PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA
PR
PTC Therapeutics, Inc. Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA
CI
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza as a Treatment for AADC Deficiency
AQ
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza? as a Treatment for AADC Deficiency
CI
PTC Therapeutics Provides Key Regulatory Updates
PR
Transcript : PTC Therapeutics, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 04:05 PM
Transcript : PTC Therapeutics, Inc. Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 01:30 PM
PTC Therapeutics Shares Jump Following Q4 Results
MT
TD Cowen Cuts Price Target on PTC Therapeutics to $30 From $32, Maintains Market Perform Rating
MT
RBC Raises Price Target on PTC Therapeutics to $28 From $22, Keeps Sector Perform Rating
MT
PTC Therapeutics Q4 Loss Narrows, Sales Up; Sets Guidance; Shares Slump After-Hours
MT
PTC Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Transcript : PTC Therapeutics, Inc., Q4 2023 Earnings Call, Feb 29, 2024
PTC Therapeutics: Q4 Earnings Snapshot
AQ
PTC Therapeutics, Inc. Provides Earnings Guidance for the Year 2024
CI
Earnings Flash (PTCT) PTC THERAPEUTICS Posts Q4 Revenue $307.1M, vs. Street Est of $317.9M
MT
PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PTCT Stock
  4. News PTC Therapeutics, Inc.